Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 240 participants.
Also called NCT07298993
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 240 participants
- Registry
-
NCT07298993
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT07298993. Randomized; quadruple masking; primary purpose treatment. Start 2026-02-02 (actual); primary completion 2029-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
- Acronym
- DEPRESCRIBE
- Condition
- Heart Failure
- Condition
- HFpEF
- Condition
- HFpEF - Heart Failure With Preserved Ejection Fraction
- Intervention (Drug)
- Placebo (matching)
- Intervention (Drug)
- Beta-blockers
- Lead sponsor
- Weill Medical College of Cornell University
- Collaborator
- National Institute on Aging (NIA)
- Collaborator
- Kaiser Foundation Research Institute
Record details
- Record id
cardio:ct-nct07298993- Content hash
d8106feb8e8a4e88c661481e7c72524fcb4b774c55492e0c5de4f467fe789d09